The authors hypothesized that TGF-β receptor inhibition may alter pancreatic ductal adenocarcinoma progression and antitumor immunity in the tumor microenvironment.
[Nature Communications]
Sorry, but the selected Zotpress account can't be found.
Home Newsletters Immune Regulation News Cell Death-Induced Immunogenicity Enhances Chemoimmunotherapeutic Response by Converting Immune-Excluded Into T Cell...
